62 results
D
SCNI
Scinai Immunotherapeutics Ltd
12 Jan 24
$1.69 mm in equity / options / securities to be acquired, sold $1.69 mm, 4 investors
7:32am
instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under … this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
9:58am
such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein “SEC Reports
424B3
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Prospectus supplement
9:57am
was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference
6-K
EX-10.1
SCNI
Scinai Immunotherapeutics Ltd
2 Jan 24
Report of Foreign Private Issuer
9:26am
or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein “SEC
D
SCNI
Scinai Immunotherapeutics Ltd
3 Oct 23
$1.33 mm in equity / options / securities to be acquired, sold $1.33 mm, 1 investor
12:38pm
, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials … under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
6-K
EX-1.1
dwleg9
19 Sep 23
Report of Foreign Private Issuer
3:06pm
424B3
zvw9hexi8jbtr45i wr6
7 Sep 23
Prospectus supplement
5:27pm
6-K
EX-99.1
tf6zo2fswzm
12 Jul 23
Report of Foreign Private Issuer
12:00am
10-K
EX-14.1
2jxruo
17 Apr 23
Annual report
4:06pm
10-K
EX-4.1
b2ov3vekfs 4rnf
17 Apr 23
Annual report
4:06pm
10-K
4lv6njx7qu 9z
17 Apr 23
Annual report
4:06pm
6-K
EX-1.1
6i2znaa
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
1u63mzkd3kzo
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-1.1
1t53g7r
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
7rylzwa0h1jeh4in
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
424B3
04mlf9vmzjxik43iot9v
16 Nov 22
Prospectus supplement
12:01pm
6-K
EX-99.1
v9wqoneqrv
10 Nov 22
Current Report
5:28pm
F-1
pknx8qzrsdfaqu vx7p
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-99.1
9s7c8
12 Apr 22
Report of Foreign Private Issuer
4:15pm